# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-25-017756
Filing Date
2025-10-10
Accepted
2025-10-10 16:06:00
Documents
84
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | form6-k.htm iXBRL | 6-K | 23858
2 | EX-99.1 | ex99-1.htm iXBRL | EX-99.1 | 1402657
3 | EX-99.2 | ex99-2.htm | EX-99.2 | 225257
| Complete submission text file | 0001493152-25-017756.txt |  | 8669746

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | gnta-20250630.xsd | EX-101.SCH | 60072
5 | XBRL CALCULATION FILE | gnta-20250630_cal.xml | EX-101.CAL | 61522
6 | XBRL DEFINITION FILE | gnta-20250630_def.xml | EX-101.DEF | 261461
7 | XBRL LABEL FILE | gnta-20250630_lab.xml | EX-101.LAB | 434954
8 | XBRL PRESENTATION FILE | gnta-20250630_pre.xml | EX-101.PRE | 362607
88 | EXTRACTED XBRL INSTANCE DOCUMENT | form6-k_htm.xml | XML | 1791324

Mailing Address OLGETTINA, NO. 58 MILAN L6 20132
Business Address OLGETTINA, NO. 58 MILAN L6 20132 39-02-2643-6639
Genenta Science S.p.A. (Filer) CIK: 0001838716 (see all company filings)

EIN.: 000000000 | State of Incorp.: L6
Type: 6-K | Act: 34 | File No.: 001-41115 | Film No.: 251388160
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)